Physician

John William Karth, M.D.

According to 2025 Medicare claims, John Karth, M.D. (NPI: 1588862320) practices ophthalmology in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is OREGON EYE CONSULTANTS LLC (NPI: 1023199734; TIN: 93-1292903) and primary practice location at 97471-8899.

Karth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,235 traditional Medicare patients, billed 122,773 HCPCS/CPT codes, and received $5,276,381 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 945 prescription claims across 291 beneficiaries totaling $64,633 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 22 records totaling $569. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,120,167 to $5,276,381. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.3M2015 Medicare payment: $1,120,167 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,329,558 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,465,653 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,127,475 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,853,108 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,536,492 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,517,315 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,549,370 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,569,199 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,276,381 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,03313,082$1,120,167
20161,06614,040$1,329,558
20171,06514,293$1,465,653
20181,02715,081$2,127,475
20191,05215,060$1,853,108
202099515,562$3,536,492
20211,04014,190$3,517,315
20221,06615,905$3,549,370
20231,16980,197$4,569,199
20241,235122,773$5,276,381

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$41K$82K2015 Drug cost: $57,847 (USD; Tot_Drug_Cst)2016 Drug cost: $57,185 (USD; Tot_Drug_Cst)2017 Drug cost: $62,637 (USD; Tot_Drug_Cst)2018 Drug cost: $74,816 (USD; Tot_Drug_Cst)2019 Drug cost: $80,311 (USD; Tot_Drug_Cst)2020 Drug cost: $71,022 (USD; Tot_Drug_Cst)2021 Drug cost: $74,926 (USD; Tot_Drug_Cst)2022 Drug cost: $81,707 (USD; Tot_Drug_Cst)2023 Drug cost: $73,889 (USD; Tot_Drug_Cst)2024 Drug cost: $64,633 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154181,100$57,847
2016324856$57,185
2017328875$62,637
2018292831$74,816
2019277766$80,311
2020244704$71,022
2021248797$74,926
2022284957$81,707
2023238850$73,889
2024291945$64,633

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5222,842$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more494814$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6971,064$59
92134Imaging of retina1,1893,705$30
J2777Injection, faricimab-svoa, 0.1 mg267104,400$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium29928$10,186
Bromfenac SodiumBromfenac Sodium852,388$9,978
DifluprednateDifluprednate732,020$8,236
Prednisolone AcetatePrednisolone Acetate1234,767$4,468
IlevroNepafenac12329$4,310

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$569ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John William Karth, M.D.?

Tedicare shows public-source Medicare data for John William Karth, M.D. (NPI 1588862320), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John William Karth, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John William Karth, M.D.?

John William Karth, M.D. is linked to OREGON EYE CONSULTANTS LLC (billing NPI 1023199734) in the available physician profile data.

Does John William Karth, M.D. have Open Payments data?

John William Karth, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.